Sid Angle is the Co-founder and Chief Executive Officer of Regenosine, focusing on developing regenerative therapies for osteoarthritis. They possess extensive experience in orthopedic research, having previously served as a Senior Research Scientist and Global R&D Manager at Zimmer Biomet. Additionally, Sid held roles at NYU Langone Health and Carnegie Mellon University, contributing to innovative projects in medical technology and regenerative medicine. Sid earned a PhD from the University of Illinois at Chicago and holds an education from the Massachusetts Institute of Technology's Sloan School of Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices